Expression of transient receptor potential cation channel subfamily M member 8 in gastric cancer and its clinical significance

Xu,Qiqi; Kong,Na; Zhang,Jun; Bai,Nan; Bi,Jingtao; Li,Wendong

doi:10.3892/etm.2021.9808

Expression of transient receptor potential cation channel subfamily M member 8 in gastric cancer and its clinical significance

Authors:
- Qiqi Xu
- Na Kong
- Jun Zhang
- Nan Bai
- Jingtao Bi
- Wendong Li
View Affiliations

Affiliations: Department of General Surgery, Beijing Jishuitan Hospital, Beijing 100035, P.R. China
Published online on: February 19, 2021 https://doi.org/10.3892/etm.2021.9808
Article Number: 377
Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Transient receptor potential cation channel subfamily M member (TRPM8) is abnormally expressed in many malignant tumors, such as breast cancer and pancreatic cancer, but its expression in gastric cancer (GC) has remained unclear. The present study aimed to detect TRPM8 expression and to explore its clinical significance in GC. Western blotting and immunohistochemistry were used to detect the protein expression of TRPM8 in 134 pairs of GC and adjacent healthy tissues. The association of TRMP8 with the 5‑year overall survival rate of patients with GC was assessed using a Cox regression model. TRPM8 protein expression was significantly elevated (P<0.05) in gastric tumor cells (SUN‑1, AGS, SNU‑5 and NCI‑N87) and was significantly associated with tumor diameter (P=0.003), Tumor‑Node‑Metastasis stage (P=0.003), lymph node metastasis (P=0.001) and cancer cell remote metastasis (P=0.010) in patients with GC. The expression of TRPM8 protein was significantly higher in GC patients with a tumor diameter of ≥2.5 cm. Additionally, TRPM8 protein expression in patients with metastases was significantly higher compared with patients without metastasis. Cox regression analysis revealed that TRPM8 protein expression was an independent risk factor for prognosis (odds ratio, 1.625; 95% CI=0.552‑3.128) in patients with GC. In addition, the 5‑year overall survival rate of patients with high expression of TRPM8 protein (64.44%) in GC was significantly lower compared with patients with low expression (12.36%). TRPM8 was highly expressed in GC tissues and may promote GC cell proliferation and metastasis in vivo.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.PubMed/NCBI View Article : Google Scholar
2	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
3	Shiraishi N, Yasuda K and Kitano S: Laparoscopic gastrectomy with lymph node dissection for gastric cancer. Gastric Cancer. 9:167–176. 2006.PubMed/NCBI View Article : Google Scholar
4	Jackson C, Cunningham D and Oliveira J: ESMO Guidelines Working Group. Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 20 (Suppl 4):S34–S36. 2009.PubMed/NCBI View Article : Google Scholar
5	Jiang L, Yang KH, Guan QL, Chen Y, Zhao P and Tian JH: Survival benefit of neoadjuvant chemotherapy for resectable cancer of the gastric and gastroesophageal junction: A meta-analysis. J Clin Gastroenterol. 49:387–394. 2015.PubMed/NCBI View Article : Google Scholar
6	Tsavaler L, Shapero MH, Morkowski S and Laus R: Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Res. 61:3760–3769. 2001.PubMed/NCBI
7	Liu SC, Lu HH, Cheng LH, Chu YH, Lee FP, Wu CC and Wang HW: Identification of the cold receptor TRPM8 in the nasal mucosa. Am J Rhinol Allergy. 29:e112–e116. 2015.PubMed/NCBI View Article : Google Scholar
8	Borowiec AS, Sion B, Chalmel F, D Rolland A, Lemonnier L, De Clerck T, Bokhobza A, Derouiche S, Dewailly E, Slomianny C, et al: Cold/menthol TRPM8 receptors initiate the cold-shock response and protect germ cells from cold-shock-induced oxidation. FASEB J. 30:3155–3170. 2016.PubMed/NCBI View Article : Google Scholar
9	Bautista DM, Siemens J, Glazer JM, Tsuruda PR, Basbaum AI, Stucky CL, Jordt SE and Julius D: The menthol receptor TRPM8 is the principal detector of environmental cold. Nature. 448:204–208. 2007.PubMed/NCBI View Article : Google Scholar
10	Yudin Y and Rohacs T: Regulation of TRPM8 channel activity. Mol Cell Endocrinol. 353:68–74. 2012.PubMed/NCBI View Article : Google Scholar
11	Yamamura H, Ugawa S, Ueda T, Morita A and Shimada S: TRPM8 activation suppresses cellular viability in human melanoma. Am J Physiol Cell Physiol. 295:C296–C301. 2008.PubMed/NCBI View Article : Google Scholar
12	Chodon D, Guilbert A, Dhennin-Duthille I, Gautier M, Telliez MS, Sevestre H and Ouadid-Ahidouch H: Estrogen regulation of TRPM8 expression in breast cancer cells. BMC Cancer. 10(212)2010.PubMed/NCBI View Article : Google Scholar
13	Shan Y, Xu Z, Chang Z, Wu D, Wang Y, Yao X, Ng CF and Chan FL: Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2-independent and RACK1-mediated mechanism of HIF-1α stabilization. J Pathol. 234:514–525. 2014.PubMed/NCBI View Article : Google Scholar
14	Yee NS, Chan AS, Yee JD and Yee RK: TRPM7 and TRPM8 ion channels in pancreatic adenocarcinoma: Potential roles as cancer biomarkers and targets. Scientifica (Cairo). 2012(415158)2012.PubMed/NCBI View Article : Google Scholar
15	Wang Y, Yang Z, Meng Z, Cao H, Zhu G, Liu T and Wang X: Knockdown of TRPM8 suppresses cancer malignancy and enhances epirubicin-induced apoptosis in human osteosarcoma cells. Int J Biol Sci. 10:90–102. 2013.PubMed/NCBI View Article : Google Scholar
16	Valero ML, Mello de Queiroz F, Stühmer W, Viana F and Pardo LA: TRPM8 ion channels differentially modulate proliferation and cell cycle distribution of normal and cancer prostate cells. PLoS One. 7(e51825)2012.PubMed/NCBI View Article : Google Scholar
17	Liu Z, Wu H, Wei Z, Wang X, Shen P, Wang S, Wang A, Chen W and Lu Y: TRPM8: A potential target for cancer treatment. J Cancer Res Clin Oncol. 142:1871–1881. 2016.PubMed/NCBI View Article : Google Scholar
18	Namer B, Seifert F, Handwerker HO and Maihöfner C: TRPA1 and TRPM8 activation in humans: Effects of cinnamaldehyde and menthol. Neuroreport. 16:955–959. 2005.PubMed/NCBI View Article : Google Scholar
19	Li Q, Wang X, Yang Z, Wang B and Li S: Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24. Oncology. 77:335–341. 2009.PubMed/NCBI View Article : Google Scholar
20	Shimada K, Uzawa K, Kato M, Endo Y, Shiiba M, Bukawa H, Yokoe H, Seki N and Tanzawa H: Aberrant expression of RAB1A in human tongue cancer. Br J Cancer. 92:1915–1921. 2005.PubMed/NCBI View Article : Google Scholar
21	Liu B, Fan L, Balakrishna S, Sui A, Morris JB and Jordt SE: TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain. 154:2169–2177. 2013.PubMed/NCBI View Article : Google Scholar
22	Patel R, Gonçalves L, Leveridge M, Mack SR, Hendrick A, Brice NL and Dickenson AH: Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: A comparison with topical menthol. Pain. 155:2097–2107. 2014.PubMed/NCBI View Article : Google Scholar
23	Bödding M: TRP proteins and cancer. Cell Signal. 19:617–624. 2007.PubMed/NCBI View Article : Google Scholar
24	Shapovalov G, Ritaine A, Skryma R and Prevarskaya N: Role of TRP ion channels in cancer and tumorigenesis. Semin Immunopathol. 38:357–369. 2016.PubMed/NCBI View Article : Google Scholar
25	Jiang Y, Gou H, Zhu J, Tian S and Yu L: Lidocaine inhibits the invasion and migration of TRPV6-expressing cancer cells by TRPV6 downregulation. Oncol Lett. 12:1164–1170. 2016.PubMed/NCBI View Article : Google Scholar
26	Orfanelli U, Wenke AK, Doglioni C, Russo V, Bosserhoff AK and Lavorgna G: Identification of novel sense and antisense transcription at the TRPM2 locus in cancer. Cell Res. 18:1128–1140. 2008.PubMed/NCBI View Article : Google Scholar
27	Knowlton WM and McKemy DD: TRPM8: From cold to cancer, peppermint to pain. Curr Pharm Biotechnol. 12:68–77. 2011.PubMed/NCBI View Article : Google Scholar
28	Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.PubMed/NCBI View Article : Google Scholar
29	Colston KW, Berger U and Coombes RC: Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 333:188–191. 1989.PubMed/NCBI View Article : Google Scholar
30	Bidaux G, Borowiec AS, Gordienko D, Beck B, Shapovalov GG, Lemonnier L, Flourakis M, Vandenberghe M, Slomianny C, Dewailly E, et al: Epidermal TRPM8 channel isoform controls the balance between keratinocyte proliferation and differentiation in a cold-dependent manner. Proc Natl Acad Sci USA. 112:E3345–E3354. 2015.PubMed/NCBI View Article : Google Scholar
31	Yee NS: Roles of TRPM8 Ion channels in cancer: Proliferation, survival, and invasion. Cancers (Basel). 7:2134–2146. 2015.PubMed/NCBI View Article : Google Scholar
32	Denda M, Tsutsumi M and Denda S: Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: Role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis. Exp Dermatol. 19:791–795. 2010.PubMed/NCBI View Article : Google Scholar
33	Zhang L, An X, Wang Q and He M: Activation of cold-sensitive channels TRPM8 and TRPA1 inhibits the proliferative airway smooth muscle cell phenotype. Lung. 194:595–603. 2016.PubMed/NCBI View Article : Google Scholar
34	Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE and Hall DM: Molecular interactions in cancer cell metastasis. Acta Histochem. 112:3–25. 2010.PubMed/NCBI View Article : Google Scholar
35	Okamoto Y, Ohkubo T, Ikebe T and Yamazaki J: Blockade of TRPM8 activity reduces the invasion potential of oral squamous carcinoma cell lines. Int J Oncol. 40:1431–1440. 2012.PubMed/NCBI View Article : Google Scholar
36	Du GJ, Li JH, Liu WJ, Liu YH, Zhao B, Li HR, Hou XD, Li H, Qi XX and Duan YJ: The combination of TRPM8 and TRPA1 expression causes an invasive phenotype in lung cancer. Tumour Biol. 35:1251–1261. 2014.PubMed/NCBI View Article : Google Scholar
37	Yang ZH, Wang XH, Wang HP and Hu LQ: Effects of TRPM8 on the proliferation and motility of prostate cancer PC-3 cells. Asian J Androl. 11:157–165. 2009.PubMed/NCBI View Article : Google Scholar
38	Du JD, Zheng X, Chen YL, Huang ZQ, Cai SW, Jiao HB, Zhu ZM and Hu B: Elevated transient receptor potential melastatin 8 (TRPM8) expression is correlated with poor prognosis in pancreatic cancer. Med Sci Monit. 24:3720–3725. 2018.PubMed/NCBI View Article : Google Scholar
39	Xiao N, Jiang LM, Ge B, Zhang TY, Zhao XK and Zhou X: Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder. Tumour Biol. 35:11499–11504. 2014.PubMed/NCBI View Article : Google Scholar
40	Zhao W and Xu H: High expression of TRPM8 predicts poor prognosis in patients with osteosarcoma. Oncol Lett. 12:1373–1379. 2016.PubMed/NCBI View Article : Google Scholar
41	Lu HF, Hsueh SC, Yu FS, Yang JS, Tang NY, Chen SC and Chung JG: The role of Ca2+ in (-)-menthol-induced human promyelocytic leukemia HL-60 cell death. In Vivo. 20:69–75. 2006.PubMed/NCBI
42	Bhatia SP, Mcginty D, Letizia CS and Api AM: Fragrance material review on l-menthol. Food Chem Toxicol. 46 (Suppl 11):S224–S227. 2008.PubMed/NCBI View Article : Google Scholar